Tony Cass is currently Professor of Chemical Biology, in the Department of Chemistry at Imperial College London and a Fellow of the Royal Society of Chemistry. He trained originally as a chemist with degrees from the Universities of York and Oxford. He pioneered the use of synthetic electron transfer mediators for enzyme biosensors and his work in this area led to the development of the first electronic blood glucose measuring system, commercialized by MediSense Inc. (now part of Abbott Diagnostics), and the award of the Royal Society's Mullard Medal (along with Professor HAO Hill FRS and Dr MJ Green).
Most of his current research is focused on using engineered proteins and peptides as well as nucleic acid aptamers with micro-and nano-structured materials and devices for both clinical and high throughput analysis. His research also includes the development of new nanomaterials based proteomic methods and sensor technologies for stem cell bioreactors. He has published over 100 papers and edited 3 books. In addition, he is a Visiting Professor of the Chinese Academy of Sciences and the Universiti of Teknologi Malaysia.
In addition to his academic research, he has been a member of several Research Council Committees, and is a member of the Scientific Advisory Boards of StabiliTech Ltd PlastiCell Ltd. and INSPIRE (Irish Nanotechnology Consortium), as well as consulting for European and North American biotechnology, intellectual property diagnostics and investment companies.